UE
Uy Ear Mizuho Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
20
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
70%
Neutral
30%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $19 |
180%
upside
| 1 | -0.44% |
0
%
| 2 Dec ‘25 2 days ago |
|
|
|
Neutral
Maintained
| $29 |
9%
upside
| 3 | – |
–
| 2 Dec ‘25 2 days ago |
|
|
|
Outperform
Maintained
| $37 |
19%
upside
| 3 | +46% |
0
%
| 28 Nov ‘25 6 days ago |
|
|
|
Outperform
Upgraded
| $10 |
153%
upside
| 2 | -7.3% |
0
%
| 19 Nov ‘25 15 days ago |
|
|
|
Outperform
Upgraded
| $26 |
14%
upside
| 4 | -12% |
0
%
| 5 Nov ‘25 29 days ago |
|
|
|
Outperform
Maintained
| $45 |
54%
upside
| 1 | -1.7% |
0
%
| 27 Oct ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $60 |
160%
upside
| 2 | -51% |
0
%
| 25 Sep ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $56 |
81%
upside
| 2 | +57% |
0
%
| 24 Sep ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $85 |
300%
upside
| 2 | +12% |
0
%
| 15 May ‘25 6 months ago |
|